ProKidney Change in Accounts Payable 2021-2025 | PROK

ProKidney change in accounts payable from 2021 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

ProKidney Change in Accounts Payable 2021-2025 | PROK

ProKidney change in accounts payable from 2021 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$70B
Zoetis (ZTS)$68.3B
Takeda Pharmaceutical (TAK)$47.7B
Daiichi Sankyo, - (DSNKY)$47.6B
BeOne Medicines - (ONC)$35.2B
Sandoz Group AG (SDZNY)$26.1B
Summit Therapeutics (SMMT)$19.8B
Merck (MKKGY)$17.1B
Shionogi (SGIOY)$15.2B
United Therapeutics (UTHR)$14.1B
Neurocrine Biosciences (NBIX)$13.2B
Orion OYJ (ORINY)$10.8B
IPSEN (IPSEY)$10.6B
Madrigal Pharmaceuticals (MDGL)$8.2B
Corcept Therapeutics (CORT)$7.6B
Grifols, S.A (GRFS)$7.4B
Ionis Pharmaceuticals (IONS)$7B
Stevanato Group S.p.A (STVN)$6.9B
Hikma Pharmaceuticals Plc (HKMPF)$5.3B
Ono Pharmaceutical (OPHLF)$5.1B
Soleno Therapeutics (SLNO)$3.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)$3B
Crinetics Pharmaceuticals (CRNX)$2.9B
NewAmsterdam Pharma (NAMS)$2.8B
Hypermarcas (HYPMY)$2.7B
Catalyst Pharmaceuticals (CPRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.4B
Ocular Therapeutix (OCUL)$2.2B
Endo (NDOI)$1.8B
Dyne Therapeutics (DYN)$1.8B